Allucent

Allucent is a global Contract Research Organization (CRO) and drug development consultancy focused on partnering with small and mid-sized biopharmaceutical companies. Established in 2022 through the merger of CATO SMS and Pharm-Olam, Allucent aims to address the unique challenges these companies face in advancing therapies from development through clinical trials. The name "Allucent" reflects its mission to illuminate opportunities in drug development. With a presence in North America, Europe,